Document is current
Any future updates will be listed below
-
Authors
Sakurai, Toshiyuki
Omori, Teppei
Tanaka, Hiroki
Ito, Takahiro
Ando, Katsuyoshi
Yamamura, Takeshi
Nanjjo, Sohachi
Osawa, Satoshi
Takeda, Teruyuki
Watanabe, Kenji
Hiraga, Hiroto
Yamamoto, Shuji
Ozeki, Keiji
Tanaka, Shinji
Tajiri, Hisao
Saruta, Masayuki https://orcid.org/0000-0001-8172-3240
,
Akutagawa, Tsuyoshi
Aoyama, Nobuo
Iguchi, Toshihiro
Endo, Katsuya
Esaki, Motohiro
Ogata, Haruhiko
Oka, Shiro
Omiya, Naoki
Kagaya, Takeshi
Kakimoto, Kazuki
Kobayashi, Taku
Sagami, Shintaro
Sakuraba, Hirotake
Shinzaki, Shinichiro
Sugimoto, Ken
Takao, Masaki
Torisu, Takehiro
Nakajima, Atsushi
Nakamichi, Konosuke
Nakamura, Masanao
Nakase, Hiroshi
Nishiyama, Ryuhei
Hayashi, Yukie
Hayashida, Mari
Hiraoka, Sakiko
Fuijya, Mikihiro
Fukada, Norimasa
Fukuda, Masayuki
Mihara, Hiroshi
Yokoyama, Kaoru
Yoshida, Yuicihiro
Wagatsuma, Kohei
- License Information
-
More Information
Article History
Received: 9 April 2023
Accepted: 27 June 2023
First Online: 21 July 2023
Declarations
:
: The following authors have no competing interests in this study or its publication: Toshiyuki Sakurai, Takahiro Ito, Katsuyoshi Andoh, Takeshi Yamamura, Sohachi Nanjo, Susumu Osawa, Teruyuki Takeda, Hiroto Hiraga, Shuji Yamamoto, Keiji Ozeki, Shinji Tanaka, and Hisao Tajiri. Teppei Omori received honoraria (lecture fees) from Takeda Pharmaceutical Co. Ltd. Hiroki Tanaka received honoraria (lecture fees) from JIMRO Co. Ltd., AbbVie GK, EA Pharma Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., Kissei Pharmaceutical Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceutical K.K., Nikkiso Co. Ltd., Nippon Kayaku Co. Ltd., and Takeda Pharmaceutical; and research grants from AbbVie GK, Janssen Pharmaceutical K.K., EA Pharma, and Takeda Pharmaceutical. Katsunori Andoh received honoraria (lecture fees) from Nippon Kayaku Co. Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co. Ltd., AbbVie GK., JIMRO Co. Ltd., EA Pharma Co. Ltd., Kyorin Pharmaceutical Co. Ltd., ZERIA Pharmaceutical Co. Ltd., Aspen Japan K.K., Sandoz K.K. Kenji Watanabe received honoraria (lecture fees) from AbbVie GK, EA Pharma Co. Ltd, Kissei Pharmaceutical Co. Ltd., Pfizer Pharmaceutical Co. Ltd., Takeda Pharmaceutical, Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd., and Mochida Pharmaceutical Co. Ltd.; and research grants from EA Pharma Co. Ltd., Takeda Pharmaceutical, and EP Group Ltd.; a scholarship from AbbVie GK, EA Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corporation, JIMRO Co. Ltd., and Nippon Kayaku Co. Ltd.; an endowed chair from AbbVie GK, EA Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd., ZERIA Pharmaceutical Co. Ltd., JIMRO Co. Ltd, Otsuka Pharmaceutical Factory, Asahi Kasei Medical Co. Ltd., and Mochida Pharmaceutical Co. Ltd. Masayuki Saruta received honoraria (lecture fees) from AbbVie GK, Mitsubishi Tanabe Pharma, Janssen Pharma K.K., and Takeda Pharmaceutical Co. Ltd.; and scholarship/research grants from EA Pharma Co. Ltd., ZERIA Pharmaceutical Co. Ltd., Kissei Pharmaceutical Co. Ltd., and Mochida Pharmaceutical Co. Ltd.
